Tackling Myelofibrosis Anemia and Fatigue: How Ruxolitinib Alleviates Symptoms and Boosts Survival Rates
Myelofibrosis, a rare myeloproliferative neoplasm, presents devastating problems for patients, including severe anemia leading to debilitating fatigue, shortness of breath, and reduced quality of life; splenomegaly causing abdominal pain and early satiety; and bone marrow fibrosis that impairs blood cell production, often culminating in cytopenias and a median survival of just 3-5 years without intervention.
Мне нравится
Комментарий
Перепост
